Literature DB >> 19691118

Characterization of antibody aggregation: role of buried, unpaired cysteines in particle formation.

Stephen R Brych1, Yatin R Gokarn, Heather Hultgen, Riki J Stevenson, Rahul Rajan, Masazumi Matsumura.   

Abstract

Proteins are susceptible to degradation upon exposure to a variety of stresses during product manufacturing, transportation and storage. In this study, we investigated the aggregation properties of a monoclonal antibody during agitation stress. Agitation exclusively led to insoluble aggregates, or particle formation. Removal or modification of the air-liquid interface with a surfactant (e.g., polysorbate) abrogated particle formation. The supernatant postagitation was analyzed using SE-HPLC, FTIR, and AUC analyses and revealed no changes in conformation and aggregation profile when compared to the nonagitated antibody sample. The antibody particles were comprised of a combination of nonnative intermolecular disulfide-linked covalent as well as noncovalent interactions. Analysis of the antibody's unpaired cysteines revealed that the nonnative intermolecular disulfide bonds were formed through buried cysteines, which suggested at least partial unfolding of the antibody domains. FTIR analysis indicated that the particulated antibody maintained significant native-like secondary structure suggesting that particle formation led to minimal structure changes, but capable of exposing free cysteines to solvent to form the nonnative intermolecular disulfide bonds. The results presented in this study indicate the importance of the interactions between the antibody and the air-liquid interface during agitation in the formation of particles and suggests that reduced disulfide bonds may play a significant role in the particulation reaction. This phenomenon can be applicable to other proteins with similar free cysteine and structural characteristics. (c) 2009 Wiley-Liss, Inc. and the American Pharmacists Association.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19691118     DOI: 10.1002/jps.21868

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  23 in total

1.  The use of native cation-exchange chromatography to study aggregation and phase separation of monoclonal antibodies.

Authors:  Shuang Chen; Hollis Lau; Yan Brodsky; Gerd R Kleemann; Ramil F Latypov
Journal:  Protein Sci       Date:  2010-06       Impact factor: 6.725

2.  Structural characterization of IgG1 mAb aggregates and particles generated under various stress conditions.

Authors:  Srivalli N Telikepalli; Ozan S Kumru; Cavan Kalonia; Reza Esfandiary; Sangeeta B Joshi; C Russell Middaugh; David B Volkin
Journal:  J Pharm Sci       Date:  2014-01-22       Impact factor: 3.534

Review 3.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

Review 4.  Analytical comparability study of recombinant monoclonal antibody therapeutics.

Authors:  Alexandre Ambrogelly; Stephen Gozo; Amit Katiyar; Shara Dellatore; Yune Kune; Ram Bhat; Joanne Sun; Ning Li; Dongdong Wang; Christine Nowak; Alyssa Neill; Gomathinayagam Ponniah; Cory King; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-03-20       Impact factor: 5.857

Review 5.  Forced degradation of recombinant monoclonal antibodies: A practical guide.

Authors:  Christine Nowak; Jason K Cheung; Shara M Dellatore; Amit Katiyar; Ram Bhat; Joanne Sun; Gomathinayagam Ponniah; Alyssa Neill; Bruce Mason; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2017-08-30       Impact factor: 5.857

Review 6.  A bottom-up approach to understanding protein layer formation at solid-liquid interfaces.

Authors:  Mark Kastantin; Blake B Langdon; Daniel K Schwartz
Journal:  Adv Colloid Interface Sci       Date:  2013-12-28       Impact factor: 12.984

7.  Increased aggregation propensity of IgG2 subclass over IgG1: role of conformational changes and covalent character in isolated aggregates.

Authors:  Heather Franey; Stephen R Brych; Carl G Kolvenbach; Rahul S Rajan
Journal:  Protein Sci       Date:  2010-09       Impact factor: 6.725

8.  Engineering and characterization of the chimeric antibody that targets the C-terminal telopeptide of the α2 chain of human collagen I: a next step in the quest to reduce localized fibrosis.

Authors:  Jolanta Fertala; Andrzej Steplewski; James Kostas; Pedro Beredjiklian; Gerard Williams; William Arnold; Joseph Abboud; Anshul Bhardwaj; Cheryl Hou; Andrzej Fertala
Journal:  Connect Tissue Res       Date:  2013-04-15       Impact factor: 3.417

9.  Rational library design by functional CDR resampling.

Authors:  Qi Zhao; Diane Buhr; Courtney Gunter; Jenny Frenette; Mary Ferguson; Eric Sanford; Erika Holland; Chitra Rajagopal; Melissa Batonick; Margaret M Kiss; Michael P Weiner
Journal:  N Biotechnol       Date:  2017-12-11       Impact factor: 5.079

10.  Comparability analysis of anti-CD20 commercial (rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches.

Authors:  Chen Li; Anthony Rossomando; Shiaw-Lin Wu; Barry L Karger
Journal:  MAbs       Date:  2013-04-25       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.